Medical Condition

cancer

Total Trials

20

Recruiting Now

20

Trial Phases

Phase 1, Phase 2, Phase 1, Phase 2

Cancer clinical trials represent the largest single category of recruiting studies worldwide, encompassing everything from early-phase safety studies of novel oncology drugs to large Phase 3 comparisons against current standard-of-care chemotherapy regimens. The field has accelerated dramatically with the rise of immunotherapy, targeted therapies, and CAR-T cell treatments that have transformed outcomes for previously untreatable malignancies.

Trials include checkpoint inhibitors (PD-1/PD-L1 agents), KRAS inhibitors, ADC (antibody-drug conjugates), combination chemotherapy regimens, radiation protocols, and surgical technique comparisons. Many trials stratify by biomarker status (PD-L1 expression, TMB, MSI-H) to identify patients most likely to benefit.

The NCI, pharmaceutical sponsors, and academic cancer centers collectively fund thousands of oncology trials annually across every cancer type.

Frequently Asked Questions — cancer Clinical Trials

How many clinical trials are currently recruiting for cancer?

ClinicalMetric currently tracks 20 actively recruiting clinical trials for cancer, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 20. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for cancer?

cancer research spans Phase 1 (2 trials), Phase 2 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a cancer clinical trial?

Eligibility criteria for cancer trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 1

Phase 2

Top Sponsors

Taipei Veterans General Hospital, Taiwan 1 trial

XEOS Medical 1 trial

Valentina Garibotto 1 trial

Rutgers, The State University of New Jersey 1 trial

Lebanese University 1 trial

cancer

Frequently Asked Questions — cancer Clinical Trials

Recruiting Clinical Trials

Exploring Physical and Psychological Needs and Quality of Life in Patients With Advanced Cancer Receiving Immunotherapy

To Assess the Correlation of High-resolution Specimen PET-CT Imaging, Using the XEOS AURA 10 PET-CT, With the Histopathology Results and Long-term Outcome of Patients Undergoing Resective Cancer Surgery.

Dynamic Whole-body PET/CT Imaging in Clinical Oncology

A Youth-led Intervention to Reduce Healthcare Disparities in Cancer Screening

Precision Therapy for Solid Tumors: Synergistic CDK4/6 Inhibition and Anti-VEGF Targeting LncRNA

Intra- and Inter-fraction Changes in Radiation Therapy

Biobank Carcinoma: Storing Blood and Protein of Patients With Cancer

Digital Monitoring in Cancer Survivors

The IMPACT Implementation-Effectiveness Trial

Text -Based Depression Screening Among Cancer Survivors

Impact of a Collaborative Program of Physical Activity of Newly-diagnosed Cancer Patients

Characterisation of the Immune Infiltrate and Molecular Features of Thymic Epithelial Tumors Tumors (TETs) (IMMUNO-TET)

From Screening to Support: A Multi-Method Analysis of HRSN Integration in Cancer Care

Re-Engaging AYA Survivors in Cancer-Related Healthcare

Assessment of Cancer-related Post-traumatic Stress in Patients and Caregivers in the Year Following Diagnosis, and Identification of Their Expectations of Personalized Support - CANDYSTRESS

Impact of Virtual Reality on the Quality of Life of Oncology Patients

DISCO: A Patient Intervention to Reduce the Financial Burden of Cancer

Immunotherapy Based on Tumor Associated Antigen-specific Immune Effector Cells

A Nutrition & Exercise Prehabilitation Intervention on Inflammatory Biomarkers in AI Cancer Patients

Young Adult Infusion Space Experience Satisfaction Survey